|
|
Volumn 285, Issue 24, 2001, Pages 3077-3078
|
|
Study indicates utility for new breast cancer prognostic marker
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
FLUOROURACIL;
METHOTREXATE;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
UROKINASE;
ADJUVANT CHEMOTHERAPY;
AXILLARY LYMPH NODE;
BREAST BIOPSY;
BREAST CANCER;
BREAST SURGERY;
CANCER CELL;
CANCER CHEMOTHERAPY;
CANCER DIAGNOSIS;
CANCER INVASION;
CANCER RECURRENCE;
CANCER RISK;
DISEASE MARKER;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HUMAN;
IMMUNOHISTOCHEMISTRY;
LYMPH NODE METASTASIS;
PRIORITY JOURNAL;
PROGNOSIS;
RISK FACTOR;
SHORT SURVEY;
TUMOR VOLUME;
VALIDATION PROCESS;
|
|
EID: 0035958333
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.285.24.3077-JMN0627-2-1 Document Type: Short Survey |
|
Times cited : (4)
|
|
References (0)
|